Sham Vitamin Study – Shame on AMA and Complicit Media

by | Oct 18, 2011


A green chalkboard with the message 'I LOVE YOU' written in white chalk.Last Monday the AMA’s journal, Archives of Internal Medicine, released a study claiming that vitamin use might lead to an earlier death. This set off a major media frenzy of exaggerated headlines.
This study is a sham and keeps getting worse and worse. Today we have new info that clearly shows that last week’s horribly flawed vitamin study is not just bad math, it is fraudulent and specifically designed to pave the way for the FDA to demand vitamins be regulated as drugs.
New independent scientific reviews of the study reveal that the study data was “adjusted†by the authors using arbitrary, non-scientific, methods to manipulate the results and distort the truth to make their point.
In our article last Tuesday, we pointed out that the study was “junk science†at its worst. The data were “observationalâ€: women in Iowa were asked what supplements they were taking three times over eighteen years—that is every six years. Who remembers what they have taken over six years?
In addition, it was all anecdotal: you didn’t have to say what you were taking specifically, just vague terms like “multivitamin.†Were the vitamins synthetic or natural? How much did they take? Did they really take it, and for how long? Did they take it to stay healthy or because they had become very ill, perhaps with cancer? No one knows.
The next day, Dr. Robert Verkerk, our scientific director, weighed in. His analysis reveals, among many other interesting points, that all of the data was “adjusted†by the authors using methods of their own choice. If you look at the study itself, the first thing you see is an adjustment for “age and energy,†whatever “energy†means in this case. After this adjustment, vitamins C, B complex, E, D, as well as calcium, magnesium, selenium, and zinc all appear to add to years lived.
This evidently wasn’t an acceptable conclusion. So two more adjustments were made. First, if you had a healthy lifestyle and took vitamin C and lived longer, the longer life was attributed largely to the healthy lifestyle and not to the vitamin C. That put everything except B complex and calcium into neutral or negative territory.
Still the authors weren’t satisfied. They adjusted again, this time for healthy eating, with the result that every supplement except calcium, B complex, and vitamin D became a contributor to an earlier death, according to this undocumented and completely loony math, and only calcium actually lengthened life. Not surprisingly, almost none of this—except possibly for the the use of copper supplements taken by 24 women at the end of the study—could be claimed to be statistically significant, even using the authors’ own methods.
The only accurate conclusion that can be drawn from this data is that supplement users are generally healthier people. The why and how and whether it is meaningful is really unknown
The authors of the study admitted they started out with a hypothesis that supplements wouldn’t add to life. It appears, although it is not revealed, that the supplement users actually lived longer than the non-supplement users. But the authors just manipulated the data until they got what they wanted and more: Supplements not only didn’t help—they were killers! And the lazy, biased, or naïve major media took it from there.
Life Extension Foundation also did its own scientific analysis of the Archives of Internal Medicine study. Among other things, it pointed out that copper and iron are pro-oxidants, so their overuse should be expected to lead to earlier mortality. It also noted that many people start taking supplements only after they become ill, which is not controlled for in any way, and that a sizeable minority of the supplements users were also taking drugs that have since been proved to be highly dangerous—patented hormones in particular—although no attempt whatever was made to control for drug use.
To pretend to control for so many factors but not to control for drug use—and to get through peer review this way—is a sad commentary on the state of medical research today. Could this be related to the overwhelming influence of drug companies on medical research in general?
Mike Adams’ NaturalNews.com also offered a close analysis of the junk science. In addition to covering what it referred to as the study’s “statistical voodoo,†it also reminded us that theArchives of Internal Medicine “receives millions of dollars in advertising from drug companies,†part of the $400 million that goes from drug companies to medical journals, and that the major media trumpeting the study in scary headlines also stay afloat from the $4.7 billion spent in Pharma-to-consumer ads (all of this data is from 2008, and is actually higher now).
As Dr. David Brownstein noted in a video interview with Adams: “This study says absolutely nothing about vitamins. If this study was done in reverse, where vitamins were shown to be effective [easily accomplished with some further data manipulation], no journal would have printed [it] because it was so poorly done.â€
It might also be worth mentioning that the results of this so-called study contradict anotherArchives of Internal Medicine study from 2009, with four times as many participants, which showed that vitamins neither helped nor hurt mortality. We have to point out, however, that the earlier study from the same journal was also junk science. The main difference between the two is that in 2009 the apparently biased authors thought they would generate controversy be saying that popular supplements didn’t help, while the clearly biased authors in 2011 took their screwy methodology right over the cliff.
After offering such shoddy work, the authors even had the temerity to advise people: “We recommend that [supplements only] be used with… symptomatic nutrient deficiency disease.†The problem is that, having set out to prove this point, the authors have only demeaned themselves with their methods.
Two other researchers, invited to comment by the journal, say that the study findings “add to the growing evidence demonstrating that certain anti-oxidant supplements, such as vitamin E, vitamin A, and beta carotene, can be harmful.†The trouble with this glib statement is that even the most “adjusted†data about these three supplements in the study is not statistically significant.
If you take a look at our web archive, you will see many articles about outrageous medical research studies and media distortions of even good studies. We can’t afford to let these pass by. At this very moment, the FDA is trying to revise the regulations governing supplements (see our Action Alert!) in a way that could raise supplement prices sky high and greatly restrict your choice. Senator Durbin has a bill in the Senate (see our Action Alert!) that would do the same. This phony Archives of Internal Medicine study will be used by the FDA and Durbin. It will fan the flames. We need to get the truth out there in response.
To do so, we have two new Action Alerts.
The first one is for doctors and scientists and will go to the editor of the Archives of Internal Medicine.
The second is for consumers, doctors, and scientists (note that we need doctors and scientists as well as consumers), and it will go to major media outlets—places like Bloomberg, AP, Reuters, NPR, Time, the New York Times, the Los Angeles Times, NBC,USA Today, the Daily Beast, and Fox, among others. It will also go to Congress because of the connection to new FDA regulations and the Durbin bill.

Please TAKE ACTION NOW!

DOCTORS AND SCIENTISTS: TO SEND YOUR MESSAGE TO THE ARCHIVES OF INTERNAL MEDICINE: 
 
Click THIS LINK to go to the Action Alert page. Once there, fill out the form with your name and address, etc., and customize your letter. We have a suggested message for you, but please feel free to add your own comments to the letter.
 
CONSUMERS, DOCTORS, AND SCIENTISTS: TO SEND YOUR MESSAGE TO CONGRESS AND MAJOR MEDIA:
 
Click THIS LINK to go to the Action Alert page. Once there, fill out the form with your name and address, etc., and customize your letter. We have a suggested message for you, but please feel free to add your own comments to the letter.
 
Source: Alliance for Natural Health

 

Ivermectin + Mebendazole taken together produce remarkably Positive Clinical Cancer Benefits in 84.4% of Patients.

The largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients has just been published—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

This groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported NO evidence of cancer (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

Bar chart showing distribution of common cancer types with breast cancer most prevalent.
Infographic on disease status and median duration since diagnosis.

Receive Our Newsletter

12 + 10 =

jQuery( document ).ready(function( $ ) { // $( "div" ).hide(); });